Document:

Warrant-Enhanced Capital Texas Fund II LLC

 Exhibit 4.10 

 

			
	 No. PB1-004
	  	Issue Date: June 9, 2009

 THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A
REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT AND/OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144
OF SUCH ACT. 
 WHITEGLOVE HOUSE CALL HEALTH, INC. 

SERIES B-1 PREFERRED STOCK PURCHASE WARRANT 
 THIS SERIES B-1 PREFERRED STOCK PURCHASE WARRANT certifies that Enhanced Capital Texas Fund II, LLC (the “Holder”) is entitled, upon the terms and subject to the
conditions hereinafter set forth, at any time on or after the issue date set forth above and on or prior to the Expiration Date, but not thereafter, to subscribe for and purchase from Whiteglove House Call Health, Inc., a Texas corporation (the
“Company”), 32,861 shares (the “Shares”) of the Company’s Series B-1 Convertible Preferred Stock, par value $0.01 per share, at a price of $2.1961 per share (the
“Exercise Price”). This Series B-1 Preferred Stock Purchase Warrant (this “Warrant”) is one of the “Warrants” issued in connection with
the issuance to Holder of a secured promissory note (the “Note”) pursuant to that certain Note Purchase Agreement dated as of April 22, 2009 (the “Purchase Agreement”),
executed by and among the Company, Holder and Accent Texas Fund II, L.P. 
 The following is a statement of the rights of the
Holder of this Warrant and the conditions to which this Warrant is subject, to which the Holder, by the acceptance of this Warrant, agrees: 
 1. Certain Definitions. 
 1.1 “Change of
Control” has the meaning set forth in the Purchase Agreement. 
 1.2 “Common Stock”
means the Company’s common stock, par value $0.01 per share. 
 1.3 “Expiration
Date” means, unless earlier terminated pursuant to Section 8 hereof, the date that is ten (10) years after the issue date set forth above. 

1.4 “IPO” means a firm commitment underwritten initial public offering of the Company’s
Common Stock pursuant to a registration statement declared effective by the Securities and Exchange Commission. 

 2. Exercise of Warrant. 

2.1 Exercise. Unless earlier terminated pursuant to Section 8 hereof, the purchase rights represented by this
Warrant are exercisable by the Holder, in whole or in part, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly executed at the Company’s principal executive office (or such other office or agency of the Company as
it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company), and upon payment of the aggregate Exercise Price of the Shares thereby purchased (by cash or by check or bank draft payable to
the order of the Company); whereupon the Holder shall be entitled to receive (or shall be deemed to have received) a certificate for the number of Shares so purchased. The Company agrees that if at the time of the surrender of this Warrant and
purchase of the Shares, the Holder shall be entitled to exercise this Warrant, the Shares so purchased shall be and be deemed to be issued to the Holder as the record owner of such Shares as of the close of business on the date on which this Warrant
shall have been exercised as aforesaid or on such later date requested by the Holder or on such earlier date agreed to by the Holder and the Company. 
 2.2 Net Exercise. Unless earlier terminated pursuant to Section 8 hereof, in lieu of exercising this Warrant by payment of cash or check or bank draft payable to the order of the Company
pursuant to Section 2.1 above, the Holder may elect to receive Shares equal to the value of this Warrant (or the portion thereof being exercised), at any time after the date hereof and before the close of business on the Expiration Date, by
surrender of this Warrant at the Company’s principal executive office (or such other office or agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company),
together with the Notice of Conversion annexed hereto, in which event the Company will issue (or shall be deemed to have issued) to the Holder, Shares in accordance with the following formula: 

 

									
	 	  	 	  	 	  	Y(A-B)	  	 
		  	X	  	=	  	A	  	

  

											
	 Where,
	  	 	X	  	  	 	=	  	  	The number of Shares to be issued to Holder;
				
		  	 	Y	  	  	 	=	  	  	The number of Shares for which the Warrant is being exercised;
				
		  	 	A	  	  	 	=	  	  	The fair market value of one Share; and
				
		  	 	B	  	  	 	=	  	  	The Exercise Price.

 2.3
Value of Shares. For the purposes of Section 2.2, the fair market value of a Share is defined as follows: 
 (i) if the exercise is conditioned upon the Company’s IPO, and if the Company’s registration statement relating to such IPO has been declared effective by the Securities and Exchange Commission,
then the fair market value shall be the initial per share offering price specified in the final prospectus with respect to the IPO; 
 (ii) if the exercise is conditioned upon a Change of Control, then the fair market value shall be the value received in such Change of Control by the holders of the securities as to which purchase rights
under this Warrant exist; 

  
 - 2 -

 (iii) if the exercise occurs after, and not in connection with the
Company’s IPO, and: 
 (1) if the Common Stock is traded on a securities exchange, the value shall be
deemed to be the average of the closing prices on such exchange or market over the thirty (30) day period ending three (3) days prior to the date of the Notice of Conversion; or 

(2) if the Common Stock is actively traded over-the-counter, the value shall be deemed to be the average of the closing
bid prices over the thirty (30) day period ending three (3) days prior to the date of the Notice of Conversion; 
 (iv) if there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Company’s Board of Directors. 

2.4 Shareholder Agreements. In connection with any exercise or conversion of this Warrant pursuant to
Section 2.1 or 2.2, the Holder shall execute and deliver the Counterpart Signature Page annexed hereto, agreeing to enter into and become a party to the Shareholder Agreements described therein and agrees that the Shares (and any shares of
Common Stock issued or issuable upon conversion thereof) shall become subject to the rights and obligations thereof; provided, however, that if, prior to the exercise or conversion of this Warrant, any of such Shareholder Agreements are amended
other than to add a new class or classes of securities in connection with an equity financing, then the Holder will not be obligated to execute such amended Shareholder Agreement unless the Holder has approved the amendment to such Shareholder
Agreement. 
 3. Nonassessable. The Company covenants that all Shares which may be issued upon the exercise of rights
represented by this Warrant will, upon exercise of the rights represented by this Warrant, be validly issued, fully paid and nonassessable and free from all taxes, liens and charges in respect of the issue thereof. Certificates for Shares purchased
hereunder shall be delivered to the Holder promptly after the date on which this Warrant shall have been exercised. 

4. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. With respect to any fraction of a share called for upon the exercise of this Warrant, an amount equal to such fraction multiplied by the then current fair market value (determined in accordance with Section 2.3) of a Share
shall be paid in cash to the Holder. 
 5. Charges, Taxes and Expenses. Issuance of certificates for Shares upon
the exercise of this Warrant shall be made without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company,
and such certificates shall be issued in the name of the Holder. 
 6. No Rights as Shareholders. This Warrant does not
entitle the Holder to any voting rights or other rights as a shareholder of the Company prior to the exercise hereof. 

  
 - 3 -

 7. Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall be a Saturday, a Sunday or a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day that is not a Saturday, Sunday or legal
holiday. 
 8. Early Termination; Automatic Conversion Upon Expiration. Notwithstanding anything in this Warrant
to the contrary, this Warrant shall terminate upon the earlier to occur of (i) the closing of a Change of Control or (ii) 360 days following the Company’s IPO. In the event that, upon the Expiration Date, the fair market value of one
Share, as determined in accordance with Section 2.3, is greater than the Exercise Price for such Share, then this Warrant, to the extent it shall not have previously been exercised or converted, shall automatically be deemed on and as of such
date to be converted into Shares pursuant to Section 2.2, and the Holder shall be entitled to receive (or shall be deemed to have received) a certificate representing such Shares issued upon such conversion to the Holder. 

9. Adjustments. The Exercise Price and the number of Shares purchasable hereunder are subject to adjustment from time to time as
set forth in this Section 9. 
 9.1 Reclassification, etc. If the Company, at any time while this Warrant,
or any portion hereof, remains outstanding and unexpired by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the same or a different number of securities or any
other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that were subject to the purchase rights
under this Warrant immediately prior to such reclassification or other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 9. 

9.2 Subdivision or Combination of Shares. In the event that the Company shall at any time subdivide the outstanding
securities as to which purchase rights under this Warrant exist, or shall issue a stock dividend on the securities as to which purchase rights under this Warrant exist, the number of securities as to which purchase rights under this Warrant exist
immediately prior to such subdivision or to the issuance of such stock dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased, and in the event that the Company shall at any time combine the
outstanding securities as to which purchase rights under this Warrant exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such combination shall be proportionately decreased, and the Exercise
Price shall be proportionately increased, effective at the close of business on the date of such subdivision, stock dividend or combination, as the case may be. 
 9.3 Cash Distributions. No adjustment on account of cash dividends or interest on the securities as to which purchase rights under this Warrant exist will be made to the Exercise Price under this
Warrant. 
 10. Notice of Certain Events. The Company shall provide the Holder with notice (similar in manner and in
substance to the notice provided by the Company to its shareholders and/or optionholders) of a Change of Control and/or an IPO, but in any event shall provide at least twenty (20) days notice prior to the closing of a Change of Control, which
notice period may be waived or shortened by or with respect to the Holder pursuant to Section 11.2. 

  
 - 4 -

 11. Miscellaneous. 

11.1 Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on
surrender and cancellation of this Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new Warrant executed in the same manner as this Warrant and of like tenor and amount. 

11.2 Waivers and Amendments. This Warrant and the obligations of the Company and the rights of the Holder under
this Warrant may be amended, waived, discharged or terminated (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely) with the written consent of the Company and
the Holder. This Warrant may not be changed, waived, discharged or terminated orally but only by a signed statement in writing. Any amendment, waiver discharge or termination effected in accordance with this Section 11.2 shall be binding upon
the Holder and the Company. 
 11.3 Notices. Any notice, request or other communication required or
permitted hereunder shall be given in accordance with the Purchase Agreement. 
 11.4 Severability. If one
or more provisions of this Warrant are held to be unenforceable under applicable law, such provision(s) shall be excluded from this Warrant and the balance of this Warrant shall be interpreted as if such provision(s) were so excluded and shall be
enforceable in accordance with its terms. 
 11.5 Successors and Assigns. Subject to compliance with
applicable federal and state securities laws, this Warrant and all rights under this Warrant are transferable in whole or in part by the Holder to any person or entity upon written notice to the Company. The transfer shall be recorded on the books
of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event of a partial
transfer, the Company shall issue to the holders one or more appropriate new warrants. Except as otherwise expressly provided in this Warrant or the Purchase Agreement, the provisions of this Warrant and the Purchase Agreement shall inure to the
benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the Company and the Holder. 
 11.6 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to the Holder, upon any breach or default of the Company under this Warrant shall impair any such
right, power, or remedy of the Holder nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or
default be deemed a waiver of any other breach or default therefore or thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on the part of the Holder of any breach or default

  
 - 5 -

 
under this Warrant or any waiver on the part of the Holder of any provisions or conditions of this Warrant must be made in writing and shall be effective only to the extent specifically set forth
in such writing. All remedies, either under this Warrant or by law or otherwise afforded to the Holder, shall be cumulative and not alternative. 
 11.7 Titles and Subtitles. The titles of the paragraphs and subparagraphs of this Warrant are for convenience of reference only and are not to be considered in construing this Warrant. 

11.8 Construction. The language used in this Warrant will be deemed to be the language chosen by the parties to
express their mutual intent and no rules of strict construction will be applied against any party. 
 11.9
Governing Law. THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF TEXAS, WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES. 
 [Remainder of page intentionally left blank.] 

  
 - 6 -

 IN WITNESS WHEREOF, the Company has caused this Series B-1 Preferred Stock Purchase Warrant
to be executed by its duly authorized officer. 
  

			
	WHITEGLOVE HOUSE CALL HEALTH, INC.
		
	By:	 	/s/ Robert A. Fabbio
		 	 Robert A. Fabbio,
 Chief
Executive Officer

  

			
	Address:
	
	 Whiteglove House Call Health, Inc.
 5300 Bee Cave Road, Building I, Suite 100
 Austin, Texas 78746

Fax: 512-233-2808
 Attn: Chief Executive
Officer
 Email: bfabbio@housecallhealth.com

with a copy (which shall not constitute notice) to: 

 

			
	 Andrews Kurth LLP

111 Congress Avenue, Suite 1700
 Austin, Texas
78701
 Fax: (512) 320-9292
 Attn:
Carmelo M. Gordian

  

			
	ACCEPTED AND AGREED:
	
	ENHANCED CAPITAL TEXAS FUND II, LLC
		
	By:	 	 
	Name:	 	 
	Title:	 	 
		
	Dated:	 	 

 NOTICE OF EXERCISE 

 

	TO:	Whiteglove House Call Health, Inc. 

 5300 Bee Cave Road, Building I, Suite 100 
 Austin, TX 78746 

ATTN: Secretary 
  

	1.	The undersigned hereby elects to purchase
                         shares (the “Shares”) of the Series B-1 Convertible
Preferred Stock, par value $0.01 per share, of Whiteglove House Call Health, Inc. pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price in full. 

 

	2.	Please issue a certificate or certificates representing the Shares in the name of the undersigned or in such other name as is specified below: 

 

			
	 
	(Print Name)
	Address: __________________________________
	
	 

  

	3.	The undersigned confirms that the undersigned is an “accredited investor”, and that the Shares are being acquired for the account of the undersigned for
investment only and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned has no present intention of distributing or selling the Shares. 

 

			
	 
	(Print Name of Entity)
		
	By:	 	 
	Name:	 	 
	Title:	 	 
		
	Dated:	 	 

 NOTICE OF CONVERSION 

 

	TO:	Whiteglove House Call Health, Inc. 

 5300 Bee Cave Road, Building I, Suite 100 
 Austin, TX 78746 

ATTN: Secretary 
  

	1.	The undersigned hereby elects to convert the attached Warrant into
                     shares (the “Shares”) of the Series B-1 Convertible Preferred Stock, par value
$0.01 per share, of Whiteglove House Call Health, Inc. pursuant to Section 2.2 of such Warrant, which conversion shall be effected pursuant to the terms of the attached Warrant. 

 

	2.	Please issue a certificate or certificates representing the Shares in the name of the undersigned or in such other name as is specified below: 

 

			
	 
	(Print Name)
	Address: __________________________________
	
	 

  

	3.	The undersigned represents that the undersigned is an “accredited investor,” and that the Shares are being acquired for the account of the undersigned for
investment and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares. 

 

			
	 
	(Print Name of Entity)
		
	By:	 	 
	Name:	 	 
	Title:	 	 
		
	Dated:	 	 

 COUNTERPART SIGNATURE PAGE 

 

	TO:	Whiteglove House Call Health, Inc. 

 5300 Bee Cave Road, Building I, Suite 100 
 Austin, TX 78746 

ATTN: Secretary 

In connection with the purchase by the undersigned pursuant to the terms of the attached Warrant of
                     shares (the “Shares”) of the Series B-1 Convertible Preferred Stock, par value $0.01 per share,
of Whiteglove House Call Health, Inc., the undersigned hereby executes and delivers, and agrees to become a party as an “Investor” under each of the Amended and Restated Investors’ Rights Agreement, Amended and Restated
Right of First Refusal and Co-Sale Agreement, and Amended and Restated Voting Agreement, all dated March 13, 2009 (as the same may be amended from time to time, collectively, the “Shareholder Agreements”).

  

			
	 
	(Print Name of Entity)
		
	By:	 	 
	Name:	 	 
	Title:	 	 
		
	Dated:	 	 

  

			
	ACKNOWLEDGED AND ACCEPTED:
	
	WHITEGLOVE HOUSE CALL HEALTH, INC.
		
	By:	 	 
	Name:	 	 
	Title:Buy-Sell Agreement-R. Fabbio-W. Rice

 Exhibit 4.11 
 BUY-SELL AGREEMENT 
 This Buy-Sell Agreement (the “Agreement”) relates to and governs certain ownership interests in Whiteglove House Call Health, Inc., a corporation organized under and governed by the laws of the
state of Texas (the “Company”), and is made and entered into as of the 13th day of June, 2007 (the “Effective Date”) by and among the Company and individuals Robert Fabbio and William Rice, MD (each individually referred to as an
“Owner” and both together collectively referred to as the “Owners”). 

RECITALS 
 WHEREAS, the Company is a corporation organized under the laws of the state of Texas, including, without limitation, the Texas Business Organizations Code, as amended from time to time, and
all other applicable federal and state laws, and is governed by the Certificate of Formation and Bylaws previously adopted by the Company and as amended from time to time (the “Governing Documents”); 

WHEREAS, the Owners desire to enter into this Agreement to set forth in writing their agreements regarding certain
transfers or proposed transfers of their shares of the capital stock of the Company (the “Ownership Interests”); 

NOW THEREFORE, in consideration of the mutual covenants, rights, and obligations set forth in this
Agreement, the benefits to be derived therefrom, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the Owners, the Owners individually and collectively agree as follows: 

TERMS 
 1. Scope of Agreement. This Agreement shall apply to all transfers other than Permitted Transfers of Ownership Interests owned by any Owner, whether such Ownership Interests
are owned as of the Effective Date or acquired thereafter. For purposes of this Agreement, the term “transfer” shall mean any sale, exchange, delivery, assignment, bequeath, pledge, mortgage, hypothecation, or other encumbrance, transfer
or disposition of any Ownership Interest, whether voluntarily, involuntarily, or by operation of law (including without limitation the laws of bankruptcy, intestacy, descent and distribution and succession). Except for Permitted Transfers, partial
transfers of Ownership Interests and transfers to anyone but the other Owner or such Owner’s estates in the event of the death of an Owner are prohibited. A “Permitted Transfer” shall mean (i) any transfer of Ownership Interests
by Owner to a trust, partnership, corporation, limited liability company or other similar entity owned exclusively by such Owner for the benefit of such Owner, or (ii) any transfer of Ownership Interests expressly permitted hereunder;
provided, however, that each transferee in such Permitted Transfer shall, as a condition precedent to such transfer, become a party to this Agreement by executing an Adoption Agreement substantially in the form attached as Annex A and
shall have all of the rights and obligations of an Owner hereunder, and all interests in any trust, partnership, corporation, limited liability company or other similar entity to which any Ownership Interests are transferred shall themselves be
deemed Ownership Interests and shall be subject to all of the provisions hereof. Such transferred Ownership Interests shall remain “Ownership Interests” hereunder, and such transferee shall be treated as an “Owner” for the
purposes of this Agreement. 
 2. Transfer for any Reason. Transfers of Owners’ Interests other
than Permitted Transfers shall be governed by this Section 2. 
 (a) In the event that either Owner (the
“Selling Party”) desires to transfer its Ownership Interest other than pursuant to a transfer defined in item (i) of the definition of Permitted 

  
 Page 1 of 5

 
Transfer, the Selling Party shall send a notice of offer (the “Offer Notice”) to the other Owner (the “Offeree Party”). The offer set forth in the Offer Notice shall be
irrevocable for a period of thirty (30) calendar days from receipt by the Offeree Party. 
 (b) Whenever an
Offer Notice has been sent by a Selling Party: 
 (i) The Purchase Price of the Ownership Interest offered for
sale by the Selling Party shall be provided by the Selling Party in the Offer Notice and shall be determined in the Selling Party’s sole discretion. The Offer Notice shall also include the terms of sale of the Selling Party’s Ownership
Interest including, without limitation, the closing date of the sale, payment dates and amounts, non-monetary terms of the proposed sale, and any other matters germane to the closing of the sale of the Selling Party’s Ownership Interest.

 (ii) If the Offeree Party elects to purchase the Selling Party’s Ownership Interest pursuant to the
provisions of this Section 2(b) and the terms contained in the Offer Notice, it must send written notice thereof to the Selling Party within thirty (30) days of its receipt of the Offer Notice. If the Offeree Party elects not to purchase
the Selling Party’s Ownership Interest within thirty (30) days, then the Selling Party must purchase the Offeree Party’s Ownership Interest for the same price and upon the same terms contained in the Offer Notice made with respect to
the Selling Party’s Ownership Interest. 
 (c) The Company shall keep at its principal place of business a
book or record containing, among other things, the name and address of each of its Owners. No transfer of any Ownership Interest shall be effective or valid unless and until all requirements of the Governing Documents shall have been fulfilled and
all of the provisions of this Agreement have been satisfied with respect to such transfer, and the transfer has been recorded in such book or record. Upon compliance with the provisions of this Agreement and with the requirements of the Governing
Documents, the Company shall record the transfer of such Ownership Interest. A copy of this Agreement shall be maintained by the Company among its records. 
 (d) Upon the closing of any purchase of any Ownership Interest pursuant to Section 2 of this Agreement, the Selling Party shall deliver to the purchaser the following: (i) the certificate or
certificates, if any, representing the Ownership Interest being sold, duly endorsed for transfer and bearing such documentary stamps, if any, as are necessary; and (ii) such assignments, certificates of authority, tax releases, consents to
transfer, instruments and evidences of title of the transferring party and of the transferring party’s compliance with this Agreement and the Governing Documents as may be reasonably required by the purchaser or by counsel for the purchaser.

 3. General Provisions. 
 (a) The stock certificates for any Ownership Interests shall be endorsed with the following restrictive legend: 
 “The shares represented by this certificate are subject to certain restrictions and agreements contained in a Buy-Sell Agreement. A copy of the Buy-Sell Agreement and all applicable amendments
thereto will be furnished by the Company to the record holder of this certificate without charge upon written request to the Company at its principal place of business or registered office.” 

(b) No amendment, modification, or other alteration to this Agreement shall be valid unless memorialized in writing and
executed by all Owners and any other parties hereto. No waiver of any provision of this Agreement shall be valid unless in writing and signed by the party or parties against whom such waiver is sought to be enforced. The failure of any party at any
time to insist upon strict 

  
 Page 2 of 5

 
performance of any condition, promise, agreement, or understanding set forth herein shall not be construed as a waiver of the right to insist upon strict performance of same or any other
condition, promise, agreement, or understanding at a future time. 
 (c) This Agreement constitutes the entire
agreement between the parties hereto with respect to the subject matter hereof. This Agreement supersedes any other agreements, representations, warranties, promises, covenants, arrangements, communications and understandings, oral or written,
express or implied, between the parties with respect to the subject matter hereof except for the agreements, representations, warranties, promises, covenants, arrangements, communications and understandings contained in this Agreement. 

(d) The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions
hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable provision had been omitted. 
 (e) Except as may be otherwise specified herein, this Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective personal or legal representatives, heirs,
successors, and assigns including, without limitation, subsequent holders of their respective Ownership Interests. 
 (f) This Agreement shall terminate and be of no further force or effect upon the earlier of (i) consummation of the transfer of all of one Owner’s Ownership Interest to the other Owner and
(ii) the closing of the first underwritten sale of common stock of the Company pursuant to a registration statement filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”) under the Securities Act of
1933, as amended. 
 (g) This Agreement shall be governed by the laws of the State of Texas without regard to its
conflicts of law principles. The venue for any and all disputes arising hereunder shall be the courts of competent jurisdiction in Travis County, Texas, the jurisdiction of which the parties hereto expressly submit. 

(h) The use of any gender herein shall be deemed to be and include the other gender, and the use of the singular herein
shall be deemed to and include the plural (and vice versa), as appropriate. 
 [Remainder of Page Intentionally Left
Blank] 

  
 Page 3 of 5

 IN WITNESS WHEREOF, each of the parties hereto has executed this Agreement of the Effective
Date in multiple counterparts, each of which constitutes an original and all of which together constitute one document. 
  

	
	OWNERS:
	
	/s/ Robert Fabbio
	Robert Fabbio
	
	/s/ William Rice
	William Rice, MD

  
 Page 4 of 5

 ANNEX A 
 ADOPTION AGREEMENT 
 This Adoption Agreement (“Adoption
Agreement”) is executed by the undersigned (the “Transferee”) pursuant to the terms of that certain Buy-Sell Agreement dated as of             ,
2007 (the “Agreement”) by and among Whiteglove House Call Health, Inc. (the “Company”), and the Owners named therein. Capitalized terms used but not defined herein shall have the respective meanings
ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, the Transferee agrees as follows: 
 1.
Acknowledgement. Transferee acknowledges that Transferee is acquiring certain shares of the capital stock of the Company (the “Stock”), which shares are subject to the terms and conditions of the
Agreement. 
 2. Agreement. As partial consideration for such transfer, Transferee (i) agrees that the Stock
acquired by Transferee shall be bound by and subject to the terms of the Agreement, to the same extent and with the same rights and obligations as the person(s) from which such Stock is received and (ii) hereby agrees to become a party to the
Agreement with the same force and effect as if Transferee were originally a party thereto. 
 3. Notice.
Any notice required or permitted by the Agreement shall be given to Transferee at the address listed beside Transferee’s signature below. 
 EXECUTED AND DATED this              day of
                    ,         . 

 

							
	TRANSFEREE:
		
	By:	 	 
		 		 	Name:	 	 
		 		 	Title:	 	 
		 		 	Address:	 	 
		 		 	 
		 		 	Fax:	 	 

 Acknowledged and accepted on
                    ,         . 

 

					
	WHITEGLOVE HOUSE CALL HEALTH, INC.
		
	By:	 	 
		 	    Name:	 	 
		 	    Title:	 	 

  
 Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}]]